Generex Subsidiary NuGenerex Diagnostics Announces CE-Mark Certification for its Rapid Point-of-Care Express II Syphilis Treponemal Assay

Stock Information for Generex Biotechnology

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Generex Biotechnology

Generex Announces Acquisition of Additional 38% of Subsidiary Olaregen Therapeutix in an Up-Market Transaction with a Share Exchange of GNBT Stock at $2.50
Generex Biotechnology Announces Plans for NuGenerex Immuno-Oncology Spinout through a Targeted Acquisition of a Public Company and Planned Merger with Kiromic
Generex Biotechnology Defines 1:1 Stock Dividend and Provides Details on Capital Structure
Generex Biotechnology Announces Update to the Previously Declared 1:1 Stock Dividend
Generex News Alert: Generex to Announce Positive Shareholder News on Monday August 12, 2019 at 8 AM Payment Details for the 1:1 GNBT Stock Dividend
Generex Biotechnology Announces Interview with President & CEO Joe Moscato
Generex Biotechnology Welcomes MediSource Partners to the NuGenerex Family of Companies
Generex Biotechnology Introduces Pantheon Medical, the Newest Member of the NuGenerex Family of Companies

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.